Kronox Lab IPO

Kronox Lab Sciences Ltd

₹14,190 /110 sharesMinimum Investment

Kronox Lab IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹136.00₹164.95₹28.95 (21.29%)

Kronox Lab IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
3 Jun ‘24 - 5 Jun ‘24₹14,190110₹129 - ₹136
Issue SizeIPO Doc
130.15Cr
RHP PDF

Subscription Status As on 05 Jun '24, 5:00 PM

  • Qualified Institutional Buyers
    89.03x
  • Non-Institutional Investor
    301.35x
  • Retail Individual Investor
    52.86x
  • Total
    116.44x

About Kronox Lab

Kronox Lab Sciences Limited manufactures high specialty fine chemicals for diversified end user industries. The company manufactures these fine chemicals in various grades of particle sizes ranging from 10 mesh to 100 mesh. These are used mainly as (i) reacting agents and raw materials in the manufacturing of active pharmaceutical ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceutical formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others. The company also undertakes custom manufacturing of these products. The company has three manufacturing units located in Vadodara, Gujarat. These are close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. These manufacturing units have an aggregate installed capacity of 7,242 tonnes per annum (TPA).;
Parent Organisation
Kronox Lab Sciences Ltd
Founded
2008
Managing Director
Mr. Jogindersingh Jaswal

Strengths & Risks

  • The company manufactures over 185 products spanning the phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, and gluconate families.
  • Its products are supplied to customers in India and more than 20 countries globally, including the US, Argentina, Mexico, Australia, Egypt, Spain, Turkey, UK, Belgium, UAE, and China.
  • The company’s products are used across a wide spectrum of industries, like pharmaceuticals, scientific and laboratory research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy, and animal health.
  • Kronox Lab Sciences is a zero debt company with a history of over a decade of operations. The latter makes it easy for potential investors to study its past performance and estimate its future prospects.
  • For the financial years ended March 31, 2021, 2022, and 2023, the company’s total income increased from Rs 62.46 crore to Rs 82.25 crore to Rs 95.58 crore, while PAT rose from Rs 9.74 crore to Rs 13.54 crore to Rs 16.83 crore, respectively.
  • The company’s products are supplied in limited quantities for specific use by application industries. Any reduction in the requirement for these products may result in loss of business for the company.
  • The company’s top 20 products contributed 60.49%, 70.58%, 68.62%, 69.85%, and 70.04% of its revenue for the nine months ended December 31, 2023, and financial years ended December 31, 2022, December 31, 2023, December 31, 2022, and December 31, 2021, respectively.
  • Most of the sales of the company’s products are to the pharmaceutical industry and for scientific research and laboratory testing. Any change in demand or change in application or processes by the company’s customers in these industries may lead to loss of revenues and profits.
  • The company’s top 10 customers contributed 45.22%, 53.58%, 50.68%, 56.18%, and 56.32% of its revenue for the nine months ended December 31, 2023, December 31, 2022, FY23, FY22, and FY21, respectively.
  • This being an offer-for-sale (OFS), the company won’t receive any proceeds from the IPO.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular129 - 136₹2 Lakh
High Networth Individual129 - 136₹2 - 5 Lakh
For Kronox Lab IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW